Allergy Therapeutics
AGY.L
#7056
Rank
NZ$0.75 B
Marketcap
$0.16
Share price
1.45%
Change (1 day)
223.87%
Change (1 year)

EPS for Allergy Therapeutics (AGY.L)

EPS in 2023: -$0.17

According to Allergy Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.17. In 2023 the company made an earnings per share (EPS) of -$0.17 a decrease over its 2022 EPS that were of -$0.04521.

EPS history for Allergy Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023-$0.17269.76%
2022-$0.04521-516.78%
2021$0.01085-54.41%
2020$0.0238095.71%
2019$0.01216-141.62%
2018-$0.02921206.98%
2017-$0.009517-82.28%
2016-$0.05370-9900.7%
2015$0.0005479-88.46%
2014$0.00474637.81%
2013$0.003444-49.58%
2012$0.006830-128.37%
2011-$0.02408-562.56%
2010$0.005205-101.26%
2009-$0.41-52.19%
2008-$0.86-13.07%
2007-$0.99230.64%
2006-$0.30182.5%
2005-$0.11-211.47%
2004$0.09510-59.61%
2003$0.24-219.2%
2002-$0.20